文献速递临床试验与 GCP

FEED1试验:足量奶喂养对比静脉输液逐步喂养用于30-33周早产儿的随机对照试验方案

The FEED1 trial: protocol for a randomised controlled trial of full milk feeds versus intravenous fluids with gradual feeding for preterm infants (30-33 weeks gestational age).
PubMed 文献 · Trials · 2022-01-20

FEED1是一项多中心、开放、平行组、随机对照优效性试验,比较出生当日启动足量奶喂养与逐步奶喂养(伴静脉输液或肠外营养)对30+0至32+6周早产儿住院时长的影响。计划在约40个英国新生儿病房招募1700名产妇(2088名婴儿),主要结局为婴儿住院时长,样本量设计用于检测2天组间差异。

要点

  • FEED1试验比较出生当日足量奶喂养(起始60 ml/kg/天)与逐步奶喂养对30-33周早产儿住院时长的影响。
  • 主要结局为婴儿住院时长,样本量2088名婴儿(1700名产妇)用于检测2天组间差异。
  • 足量奶喂养是否缩短住院时长尚待试验结果验证。

核心结论

  • 该试验旨在探究出生后24小时内启动足量奶喂养与逐步奶喂养加静脉输液或肠外营养相比,是否缩短早产儿住院时长。
  • 作者认为该试验将为早产儿喂养实践提供高质量证据,出生当日足量奶喂养可能使婴儿更早出院。

研究设计与样本

  • 多中心、开放、平行组、随机对照优效性试验,比较出生当日启动足量奶喂养与逐步奶喂养。
  • 招募对象为胎龄30+0至32+6周(含)的早产儿,在约40个英国新生儿病房进行。
  • 母亲按1:1随机分配至足量奶喂养组(起始60 ml/kg/天)或逐步喂养组(按当地常规实践)。
  • 样本量为2088名婴儿,考虑多胎后需招募1700名产妇,用于检测2天住院时长组间差异。
  • 主要分析比较组间住院时长,校正最小化变量并考虑多胎。

主要发现

  • 原文为试验方案,未报告试验结果。
  • 背景提及小型研究显示早产儿出生起经肠道足量奶喂养可能缩短住院时长,且不增加坏死性小肠结肠炎(NEC)风险。

关键数值与推荐

  • 足量奶喂养组起始奶量为60 ml/kg/天。
  • 达到足量奶喂养定义为≥140 ml/kg/天连续3天。
  • 主要结局为婴儿住院时长,样本量设计用于检测2天组间差异。
  • 出院后6周收集额外数据,计划在矫正胎龄2岁时随访。
  • 母亲挤出的母乳始终为首选奶源,最初几天可能补充配方奶或捐赠母乳。

临床怎么用

  • 原文为试验方案,未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In the UK, approximately 8% of live births are preterm (before 37 weeks gestation), more than 90% of whom are born between 30 and 36 weeks, forming the largest proportion of a neonatal units' workload. Neonatologists are cautious in initiating full milk feeds for preterm infants due to fears of necrotising enterocolitis (NEC). There is now evidence to dispute this fear. Small studies have shown that feeding preterm infants full milk feeds enterally from birth could result in a shorter length of hospital stay, which is important to parents, clinicians and NHS services without increasing the risk of NEC. This trial aims to investigate whether full milk feeds initiated in the first 24 h after birth reduces the length of hospital stay in comparison to introduction of gradual milk feeding with IV fluids or parenteral nutrition. METHODS: FEED1 is a multi-centre, open, parallel group, randomised, controlled superiority trial of full milk feeds initiated on the day of birth versus gradual milk feeds for infants born at 30+0 to 32+6 (inclusive) weeks gestation. Recruitment will take place in around 40 UK neonatal units. Mothers will be randomised 1:1 to full milk feeds, starting at 60 ml/kg day, or gradual feeds, as per usual local practice. Mother's expressed breast milk will always be the first choice of milk, though will likely be supplemented with formula or donor breast milk in the first few days. Feeding data will be collected until full milk feeds are achieved (≥ 140 ml/kg/day for 3 consecutive days). The primary outcome is length of infant hospital stay. Additional data will be collected 6 weeks post-discharge. Follow-up at 2 years (corrected gestational age) is planned. The sample size is 2088 infants to detect a between group difference in length of stay of 2 days. Accounting for multiple births, this requires 1700 women to be recruited. Primary analysis will compare the length of hospital stay between groups, adjusting for minimisation variables and accounting for multiple births. DISCUSSION: This trial will provide high-quality evidence on feeding practices for preterm infants. Full milk feeds from day of birth could result in infants being discharged sooner. TRIAL REGISTRATION: ISRCTN ISRCTN89654042 . Prospectively registered on 23 September 2019: ISRCTN is a primary registry of the WHO ICTRP network, and all items from the WHO Trial Registration dataset are included.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Mitchell EJ, Meakin G, Anderson J, et al. The FEED1 trial: protocol for a randomised controlled trial of full milk feeds versus intravenous fluids with gradual feeding for preterm infants (30-33 weeks gestational age). Trials. 2022. PMID: 35057837. doi:10.1186/s13063-021-05994-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。